Advertisement
Aimei Health Technology C... (AFJK)
Aimei Health Technology Ltd Statistics
Share Statistics
Aimei Health Technology Ltd has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 4 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 16, so 0% of the outstanding shares have been sold short.
| Short Interest | 16 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 28.93 and the forward PE ratio is null. Aimei Health Technology Ltd's PEG ratio is 0.02.
| PE Ratio | 28.93 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | -50 |
| P/FCF Ratio | -109.82 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aimei Health Technology Ltd.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04, with a Debt / Equity ratio of -0.15.
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Debt / Equity | -0.15 |
| Debt / EBITDA | -0.21 |
| Debt / FCF | -0.34 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 7.3% in the last 52 weeks. The beta is -0.05, so Aimei Health Technology Ltd's price volatility has been lower than the market average.
| Beta | -0.05 |
| 52-Week Price Change | 7.3% |
| 50-Day Moving Average | 10.97 |
| 200-Day Moving Average | 10.66 |
| Relative Strength Index (RSI) | 71.34 |
| Average Volume (20 Days) | 6.38K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -1.06M |
| Net Income | 2.55M |
| EBITDA | -1.06M |
| EBIT | -1.06M |
| Earnings Per Share (EPS) | 0.37 |
Balance Sheet
The company has 28.21K in cash and 227.7K in debt, giving a net cash position of -199.49K.
| Cash & Cash Equivalents | 28.21K |
| Total Debt | 227.7K |
| Net Cash | -199.49K |
| Retained Earnings | -1.48M |
| Total Assets | 73.81M |
| Working Capital | -786.61K |
Cash Flow
In the last 12 months, operating cash flow was -672.29K and capital expenditures 0, giving a free cash flow of -672.29K.
| Operating Cash Flow | -672.29K |
| Capital Expenditures | 0 |
| Free Cash Flow | -672.29K |
| FCF Per Share | -0.1 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AFJK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for AFJK.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 26.74 |
| Piotroski F-Score | 3 |